Inversion Surge Proves Allure Trumps Risk For Deal Makers
Salix Pharmaceuticals Ltd. on Wednesday became the latest U.S. outfit to tap into a controversial deal structure that provides a gateway to friendlier corporate tax regimes, a move companies remain more...To view the full article, register now.
Already a subscriber? Click here to view full article